Clinical Trial Update: CKD-702 Plus Irinotecan in Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CKD-702 in combination with irinotecan in gastric cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CKD-702
• Irinotecan (Irinotecan)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN